NASDAQ:ETS ETS (ETS) Stock Price, News & Analysis $0.59 +0.02 (+4.26%) As of 02:49 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock About ETS Stock (NASDAQ:ETS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get ETS alerts:Sign Up Key Stats Today's Range$0.55▼$0.5850-Day Range$0.43▼$0.7652-Week Range$0.39▼$4.23Volume46,590 shsAverage Volume93,879 shsMarket Capitalization$9.83 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Elite Express Holding Inc. is a holding company which conducts its operations through its wholly owned subsidiary, JAR Transportation Inc. It provides last-mile delivery services, primarily focused on transporting packages from distribution centers to end customers. Elite Express Holding Inc. is based in LAGUNA HILLS, Calif. Read More ETS Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks17th Percentile Overall ScoreETS MarketRank™: ETS scored higher than 17% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingETS has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageETS has only been the subject of 1 research reports in the past 90 days.Read more about ETS's stock forecast and price target. Earnings and Valuation0.7 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of ETS is -57.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioETS has a P/B Ratio of 0.72. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted1.54% of the float of ETS has been sold short.Short Interest Ratio / Days to CoverETS has a short interest ratio ("days to cover") of 4.55.Change versus previous monthShort interest in ETS has recently increased by 14.74%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldETS does not currently pay a dividend.Dividend GrowthETS does not have a long track record of dividend growth. News and Social Media4.2 / 5News Sentiment1.70 News SentimentETS has a news sentiment score of 1.70. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.47 average news sentiment score of companies.News Coverage This WeekMarketBeat has tracked 51 news articles for ETS this week, compared to 30 articles on an average week.Search Interest1 people have searched for ETS on MarketBeat in the last 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, ETS insiders have not sold or bought any company stock.Percentage Held by Insiders24.93% of the stock of ETS is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsETS has minimal institutional ownership at this time.Read more about ETS's insider trading history. Receive ETS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ETS and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ETS Stock News HeadlinesNew Bill: Representative Derrick Van Orden introduces H.R. 8532: VA Home Loan Affordability Act2 hours ago | quiverquant.comQNew Bill: Representative Jennifer Kiggans introduces H.R. 8691: Nursing is a Professional Degree Act2 hours ago | quiverquant.comQNNVC FDA = New Momentum Wave!NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for NV-387, its antiviral candidate targeting measles - a disease with no approved antiviral treatment and rising global case counts. Beyond measles, NV-387 is designed as a broad-spectrum platform targeting RSV, influenza, coronaviruses, and Mpox, giving NNVC exposure to multiple large markets as Phase II trials advance. The designation unlocks faster development timelines, financial incentives, and potential market exclusivity.May 12 at 1:00 AM | Equiscreen (Ad)Avis Budget Group Stock Short Interest Falls to 62.76%May 12 at 9:31 AM | quiverquant.comQENvue Medical, Inc. Secures Three-Year Contract Renewal for Standardized Bedside Enteral Feeding Tube Placement Protocol Across Virginia and North Carolina Health SystemMay 12 at 8:51 AM | quiverquant.comQHARVARD BIOSCIENCE ($HBIO) Releases Q1 2026 EarningsMay 12 at 8:10 AM | quiverquant.comQThe InterGroup Corporation Reports Strong Third Quarter Fiscal 2026 Financial Results with Significant Revenue GrowthMay 11 at 5:10 PM | quiverquant.comQEnergy Services of America (ESOA) Stock Rises on Q2 2026 EarningsMay 11 at 5:10 PM | quiverquant.comQSee More Headlines ETS Stock Analysis - Frequently Asked Questions How have ETS shares performed this year? ETS's stock was trading at $0.5152 at the start of the year. Since then, ETS shares have increased by 11.0% and is now trading at $0.5720. How were ETS's earnings last quarter? ETS (NASDAQ:ETS) announced its earnings results on Monday, April, 13th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business earned $0.81 million during the quarter. ETS had a negative trailing twelve-month return on equity of 19.59% and a negative net margin of 75.24%. When did ETS IPO? ETS (ETS) raised $15 million in an initial public offering (IPO) on Thursday, August 21st 2025. The company issued 3,800,000 shares at $4.00 per share. How do I buy shares of ETS? Shares of ETS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings4/13/2026Today5/12/2026Fiscal Year End11/30/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:ETS CIK2053641 Webwww.eliteexpressholding.com Phone949-758-0650FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$2.19 million Net Margins-75.24% Pretax Margin-75.15% Return on Equity-19.59% Return on Assets-18.99% Debt Debt-to-Equity RatioN/A Current Ratio44.75 Quick Ratio44.75 Sales & Book Value Annual Sales$2.78 million Price / Sales3.54 Cash FlowN/A Price / Cash FlowN/A Book Value$0.79 per share Price / Book0.74Miscellaneous Outstanding Shares16,717,000Free Float12,549,000Market Cap$9.83 million OptionableN/A BetaN/A Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (NASDAQ:ETS) was last updated on 5/12/2026 by MarketBeat.com Staff. From Our PartnersNNVC FDA = New Momentum Wave!NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for NV-387, its antiviral candidate targe...Equiscreen | SponsoredBSEM: From OTC to Nasdaq Contender!BioStem Technologies (OTC: BSEM) has posted seven consecutive profitable quarters and just released audited fi...Huge Alerts | SponsoredIf You Have $50k+ on Coinbase, This Will Ruin Your DayIn 2009, Greece's debt-to-GDP ratio hit 130%. Within 24 months... Pensions were slashed 40% overnight. Bank ac...Decentralized Masters | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredRise of the… petroyuan?On February 28th, Iran installed a yuan-denominated toll at the Strait of Hormuz - the chokepoint for one in e...Golden Portfolio | SponsoredNevada gold explorer near Kinross district draws attentionGold has surged past $5,300 per ounce, with Goldman Sachs and JPMorgan forecasting $6,000+ by end of 2026. Cen...Wall Street Logic | SponsoredYale just did the math (you owe Washington $1,500)The Yale Budget Lab calculated that current U.S. trade policy is costing the average American household betwee...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ETS Please log in to your account or sign up in order to add this asset to your watchlist. Share ETS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ETS Stock Alerts